Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

rocuronium bromide injection Principal Display Panel

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label

5 mL
Multiple dose vial

Rocuronium
Bromide Inj.
50 mg/5 mL
(10 mg/mL)

WARNING: Paralyzing Agent

For IV use only
Rx only

Peel off &
apply to syringe

NDC 0409-9558-11

WARNING:
Paralyzing Agent.
Causes Respiratory
Arrest. Facilities
must be
immediately
available for
artificial respiration

Hospira

Dist. by Hospira, Inc.
Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label

PRINCIPAL DISPLAY PANEL - 5 mL Vial Box

10 x 5 mL multiple dose vials

NDC 0409-9558-05
Contains 10 of NDC 0409-9558-11

Rocuronium
Bromide Injection

50 mg/5 mL (10 mg/mL)

WARNING: Paralyzing Agent

Rx only

For intravenous use only
WARNING: Paralyzing Agent. Causes Respiratory
Arrest. Facilities must be immediately available
for artificial respiration

Dosage: Read enclosed prescribing information.

Storage: Rocuronium Bromide Injection
should be stored under refrigeration, 2 to
8°C (36 to 46°F). DO NOT FREEZE.
Upon removal from refrigeration to room
temperature storage conditions (25°C/77°F),
use Rocuronium Bromide Injection within
60 days. Use opened vials of Rocuronium
Bromide Injection within 30 days.

Sterile, nonpyrogenic. Each mL contains:
10 mg rocuronium bromide, 2 mg sodium
acetate. Adjusted to isotonicity with
3.1 mg/mL NaCI and to a pH of 4 with acetic
acid and/or NaOH.

Hospira

PRINCIPAL DISPLAY PANEL - 5 mL Vial Box

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

10 mL
Multiple dose vial

Rocuronium
Bromide Inj.
100 mg/10 mL
(10 mg/mL)

WARNING: Paralyzing Agent

For IV use only
Rx only

Peel off &
apply to syringe

NDC 0409-9558-31

WARNING: Paralyzing
Agent. Causes
Respiratory Arrest.
Facilities must be
immediately available
for artificial respiration

Hospira

Dist. by Hospira, Inc.
Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 10 mL Vial Label

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box

10 x 10 mL multiple dose vials

NDC 0409-9558-10
Contains 10 of NDC 0409-9558-31

Rocuronium
Bromide Injection

100 mg/10 mL
(10 mg/mL)

WARNING: Paralyzing Agent

Rx only

For intravenous use only
WARNING: Paralyzing Agent. Causes
Respiratory Arrest. Facilities must be
immediately available for artificial respiration

Dosage: Read enclosed prescribing information.

Storage: Rocuronium Bromide Injection should
be stored under refrigeration, 2 to 8°C (36 to
46°F). DO NOT FREEZE. Upon removal from
refrigeration to room temperature storage
conditions (25°C/77°F), use Rocuronium Bromide
Injection within 60 days. Use opened vials of
Rocuronium Bromide Injection within 30 days.

Sterile, nonpyrogenic. Each mL contains: 10 mg
rocuronium bromide, 2 mg sodium acetate.
Adjusted to isotonicity with 3.1 mg/mL NaCI and
to a pH of 4 with acetic acid and/or NaOH.

Hospira

PRINCIPAL DISPLAY PANEL - 10 mL Vial Box
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event